克赛在STEMI患者中应用.pptVIP

  • 8
  • 0
  • 约3.01万字
  • 约 31页
  • 2019-11-28 发布于广东
  • 举报
克赛?是目前唯一拥有STEMI适应症的低分子肝素 克赛贯穿了包括UA/NSTEMI以及STEMI在内的ACS治疗始终 法安明,速碧林均没有此类大规模研究,也没有STEMI适应症 * * Patients with unstable angina or non-Q-wave myocardial infarction (NQMI) are at very high risk of acute ischaemic events. The current standard of care for patients hospitalized with these acute coronary syndromes is combination antithrombotic therapy comprising intravenous (IV) unfractionated heparin plus oral aspirin. Despite undergoing this treatment, many patients still have an acute ischaemic event. This failure may be related to the unpredictable anticoagulant response of unfractionated heparin, n

文档评论(0)

1亿VIP精品文档

相关文档